Urine biomarkers for monitoring juvenile lupus nephritis: A prospective longitudinal study

Pediatric Nephrology

Volumn 29, Issue 3, 2014, Pages 397-405

  Watson, Louise ^a,b   Tullus, Kjell ^c   Pilkington, Clarissa ^c   Chesters, Christine ^b   Marks, Stephen D ^c   Newland, Paul ^b   Jones, Caroline A ^b   Beresford, Michael W ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Biomarker; Lipocalin; Lupus; MCP1; Nephritis; NGAL

Indexed keywords

ACUTE-PHASE PROTEINS; ADOLESCENT; AGE OF ONSET; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COMPLEMENT C3; DISEASE PROGRESSION; FEMALE; GREAT BRITAIN; HUMANS; INFANT; LINEAR MODELS; LIPOCALINS; LONGITUDINAL STUDIES; LUPUS NEPHRITIS; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; TIME FACTORS; URINALYSIS;

EID: 84894257992     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-013-2668-4     Document Type: Article

References (41)

1. Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Archer N, Bailey K, Davidson J, Baildam EM, Cleary G, McCann LJ, Beresford MW (2012) Juvenile-onset SLE; disease activity, severity and damage - the UK JSLE Cohort Study. Arthritis Rheum 64:2356-2365
2. Weiss JE, Sison CP, Ilowite NT, Gottlieb BS, Eberhard BA (2007) Flares in pediatric systemic lupus erythematosus. J Rheumatol 34:1341-1344 (Pubitemid 46898119)
3. Hui M, Garner R, Rees F, Bavakunji R, Daniel P, Varughese S, Srikanth A, Andres M, Pearce F, Leung J, Lim K, Regan M, Lanyon P (2013) Lupus nephritis: a 15-year multi-centre experience in the UK. Lupus 22:328-332
4. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241-250 (Pubitemid 38140764)
5. Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, Li Vecchi M, Messa P, Sinico RA (2009) Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis 68:234-237
6. Christopher-Stine L, Siedner M, Lin J, Haas M, Parekh H, Petri M, Fine DM (2007) Renal biopsy in lupus patients with low levels of proteinuria. J Rheumatol 34:332-335
7. Isenberg DA, Rahman A, Allen E, Farewell V, Akil M, Bruce IN, D'Cruz D, Griffiths B, Khamashta M, Maddison P, McHugh N, Snaith M, Teh LS, Yee CS, Zoma A, Gordon C (2005) BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) 44:902-906 (Pubitemid 41511186)
8. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630-640
9. Marks SD, Shah V, Pilkington C, Tullus K (2010) Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis. Pediatr Nephrol 25:2283-2288
10. Watson L, Midgley A, Pilkington C, Tullus K, Marks S, Holt R, Jones C, Beresford M (2012) Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus. Lupus 21:496-501
11. Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN (2005) Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol 16:467-473 (Pubitemid 41725143)
12. Marks SD, Williams SJ, Tullus K, Sebire NJ (2008) Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis. Nephrol Dial Transplant 23:3521-3526
13. Suzuki M, Wiers KM, Klein-Gitelman MS, Haines KA, Olson J, Onel KB, O'Neil K, Passo MH, Singer NG, Tucker L, Ying J, Devarajan P, Brunner HI (2008) Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol 23:403-412
14. Rubinstein T, Pitashny M, Levine B, Schwartz N, Schwartzman J, Weinstein E, Pego-Reigosa JM, Lu TY, Isenberg D, Rahman A, Putterman C (2010) Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology (Oxford) 49:960-971
15. Hinze CH, Suzuki M, Klein-Gitelman M, Passo MH, Olson J, Singer NG, Haines KA, Onel K, O'Neil K, Silverman ED, Tucker L, Ying J, Devarajan P, Brunner HI (2009) Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum 60:2772-2781
16. Schwartz N, Rubinstein T, Burkly LC, Collins CE, Blanco I, Su L, Hojaili B, Mackay M, Aranow C, Stohl W, Rovin BH, Michaelson JS, Putterman C (2009) Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther 11:R143
17. Mina R, Brunner HI (2010) Pediatric lupus - are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheum Dis Clin N Am 36:53-80, vii-viii
18. Brunner HI, Klein-Gitelman MS, Ying J, Tucker LB, Silverman ED (2009) Corticosteroid use in childhood-onset systemic lupus erythematosus-practice patterns at four pediatric rheumatology centers. Clin Exp Rheumatol 27:155-162
19. Brunner HI, Gladman DD, Ibanez D, Urowitz MD, Silverman ED (2008) Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 58:556-562 (Pubitemid 351294890)
20. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
21. Hersh A (2011) Measures of health-related quality of life in pediatric systemic lupus erythematosus: Childhood Health Assessment Questionnaire (C-HAQ), Child Health Questionnaire (CHQ), Pediatric Quality of Life Inventory Generic Core Module (PedsQL-GC), Pediatric Quality of Life Inventory Rheumatology Module (PedsQL-RM), and Simple Measure of Impact of Lupus Erythematosus in Youngsters (SMILEY). Arthritis Care Res (Hoboken) 63 [Suppl 11]:S446-S453
22. Singh G, Athreya BH, Fries JF, Goldsmith DP (1994) Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 37:1761-1769 (Pubitemid 24371878)
23. Meiorin S, Pistorio A, Ravelli A, Iusan SM, Filocamo G, Trail L, Oliveira S, Cuttica R, Espada G, Alessio M, Mihaylova D, Cortis E, Martini A, Ruperto N (2008) Validation of the childhood health assessment questionnaire in active juvenile systemic lupus erythematosus. Arthritis Rheum 59:1112-1119
24. Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629-637
25. Brunner HI, Feldman BM, Bombardier C, Silverman ED (1999) Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 42:1354-1360 (Pubitemid 30265592)
26. Marks SD, Pilkington C, Woo P, Dillon MJ (2004) The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. Rheumatology (Oxford) 43:1186-1189 (Pubitemid 39232827)
27. Watson L, Beresford MW (2012) Urine biomarkers in juvenile-onset SLE nephritis. Pediatr Nephrol 28:363-374
28. Brunner HI, Bennett MR, Mina R, Suzuki M, Petri M, Kiani AN, Pendl J, Witte D, Ying J, Rovin BH, Devarajan P (2012) Non-invasive renal protein biomarkers are associated with histological features of lupus nephritis. Arthritis Rheum 64:2687-2697
29. Amezcua-Guerra LM, Springall R, Arrieta-Alvarado AA, Rodriguez V, Rivera-Martinez E, Castillo-Martinez D, Bojalil R (2011) C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus. Clin Lab 57:607-613
30. Al Durahim H, Al Ghamdi G, Al Seraya A, Alkhiari R, Al Sayyari A (2011) Predictors of mortality and end stage renal disease in Saudi patients with lupus nephritis. Lupus 20:1329-1335
31. Conductier G, Blondeau N, Guyon A, Nahon JL, Rovere C (2010) The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol 224:93-100
32. Schwarz M, Wahl M, Resch K, Radeke HH (2002) IFNgamma induces functional chemokine receptor expression in human mesangial cells. Clin Exp Immunol 128:285-294 (Pubitemid 34534042)
33. Wan JX, Fukuda N, Endo M, Tahira Y, Yao EH, Matsuda H, Ueno T, Matsumoto K (2007) Complement 3 is involved in changing the phenotype of human glomerular mesangial cells. J Cell Physiol 213:495-501 (Pubitemid 47509732)
34. Venkatesan BA, Mahimainathan L, Ghosh-Choudhury N, Gorin Y, Bhandari B, Valente AJ, Abboud HE, Choudhury GG (2006) PI 3 kinase-dependent Akt kinase and PKCepsilon independently regulate interferon-gamma-induced STAT1alpha serine phosphorylation to induce monocyte chemotactic protein-1 expression. Cell Signal 18:508-518 (Pubitemid 41790371)
35. Banas B, Luckow B, Moller M, Klier C, Nelson PJ, Schadde E, Brigl M, Halevy D, Holthofer H, Reinhart B, Schlondorff D (1999) Chemokine and chemokine receptor expression in a novel human mesangial cell line. J Am Soc Nephrol 10:2314-2322 (Pubitemid 29501464)
36. Kiani AN, Wu T, Fang H, Zhou XJ, Ahn CW, Magder LS, Mohan C, Petri M (2012) Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis. J Rheumatol 39:1231-1237
37. Jain S, De Petris L, Hoshi M, Akilesh S, Chatterjee R, Liapis H (2011) Expression profiles of podocytes exposed to high glucose reveal new insights into early diabetic glomerulopathy. Lab Investig 91:488-498
38. Pawar RD, Pitashny M, Gindea S, Tieng AT, Levine B, Goilav B, Campbell SR, Xia Y, Qing X, Thomas DB, Herlitz L, Berger T, Mak TW, Putterman C (2012) Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in mice. Arthritis Rheum 64:1620-1631
39. Yang CC, Hsieh SC, Li KJ, Wu CH, Lu MC, Tsai CY, Yu CL (2012) Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus. J Biomed Biotechnol 2012:759313
40. Brunner HI, Mueller M, Rutherford C, Passo MH, Witte D, Grom A, Mishra J, Devarajan P (2006) Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum 54:2577-2584 (Pubitemid 44205019)
41. Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Lai KB, Li PK, Szeto CC (2007) Intrarenal cytokine gene expression in lupus nephritis. Ann Rheum Dis 66:886-892 (Pubitemid 46999788)